Therapeutic molecules
Abstract:
The invention relates to binding molecules that bind specifically to prostate specific membrane antigen (PSMA), in particular, single human variable heavy chain domain antibodies and related methods for treatment of cancer.
Public/Granted literature
Information query
Patent Agency Ranking
0/0